EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
68 hedge funds and large institutions have $489M invested in Eagle Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+40
Holders Change %
+142.86%
% of All Funds
1.81%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.13%
New
45
Increased
13
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Jennison Associates
New York
|
-$10.7M |
2 |
GE
General Electric
Evendale,
Ohio
|
-$8.94M |
3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$7.33M |
4 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$4.56M |
5 |
DM
Deerfield Management
New York
|
-$4.41M |